chrisvoncsefalvay/vaers-narrative-generation huggingface dataset:
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Vaccination site erythema, Vaccination site warmth
Clinical narrative: injection site redness; injection site warm; she had a little soreness in the arm the first week; This spontaneous case was reported by a consumer and describes the occurrence of PAIN IN EXTREMITY (she had a little soreness in the arm the first week), VACCINATION SITE ERYTHEMA (injection site redness) and VACCINATION SITE WARMTH (injection site warm) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 016M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 06-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Feb-2021, the patient experienced VACCINATION SITE ERYTHEMA (injection site redness) and VACCINATION SITE WARMTH (injection site warm). On an unknown date, the patient experienced PAIN IN EXTREMITY (she had a little soreness in the arm the first week). The patient was treated with NAPROXEN SODIUM (ALEVE) at an unspecified dose and frequency and PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, PAIN IN EXTREMITY (she had a little soreness in the arm the first week), VACCINATION SITE ERYTHEMA (injection site redness) and VACCINATION SITE WARMTH (injection site warm) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included Tylenol and Advel
Sex: F
Vaccine: COVID19
Symptoms: Headache, Nausea, Pyrexia, Rhinorrhoea, Throat irritation
Clinical narrative: headache from crown down to ears; runny nose; temp. of 101.5; scratchy throat; nausea; This spontaneous case was reported by a nurse and describes the occurrence of HEADACHE (headache from crown down to ears), RHINORRHOEA (runny nose), NAUSEA (nausea), PYREXIA (temp. of 101.5) and THROAT IRRITATION (scratchy throat) in a 61-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 007M20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.    On 18-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 18-Feb-2021, the patient experienced HEADACHE (headache from crown down to ears), RHINORRHOEA (runny nose), PYREXIA (temp. of 101.5) and THROAT IRRITATION (scratchy throat). On an unknown date, the patient experienced NAUSEA (nausea). At the time of the report, HEADACHE (headache from crown down to ears), RHINORRHOEA (runny nose), NAUSEA (nausea), PYREXIA (temp. of 101.5) and THROAT IRRITATION (scratchy throat) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No concomitant medications reported. Treatment included Excedrin   Most recent FOLLOW-UP information incorporated above includes: On 23-Feb-2021: No specific follow-up information recorded.
Sex: M
Vaccine: COVID19
Symptoms: Rash, Vaccination site pain
Clinical narrative: Rash getting bigger and bigger; Little pain in the arm; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE PAIN (Little pain in the arm) and RASH (Rash getting bigger and bigger) in a male patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event (No adverse event history).    On 16-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 16-Jan-2021, the patient experienced VACCINATION SITE PAIN (Little pain in the arm). On 23-Jan-2021, the patient experienced RASH (Rash getting bigger and bigger). At the time of the report, VACCINATION SITE PAIN (Little pain in the arm) and RASH (Rash getting bigger and bigger) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.       No concomitant medications reported. No treatment information provided.
Age: 90.0
Sex: M
Vaccine: COVID19
Symptoms: Abdominal discomfort, Abdominal pain, Dysgeusia, Nausea
Clinical narrative: belly has been hurting; sour mouth; NAUSEA and felt like I would vomit; Stomach issues; This spontaneous case was reported by a consumer and describes the occurrence of ABDOMINAL DISCOMFORT (Stomach issues), ABDOMINAL PAIN (belly has been hurting), DYSGEUSIA (sour mouth) and NAUSEA (NAUSEA and felt like I would vomit) in a 90-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination.     Concomitant products included METOPROLOL SUCCINATE (TOPROL) for Hypertension.    On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 31-Jan-2021, the patient experienced ABDOMINAL DISCOMFORT (Stomach issues) and NAUSEA (NAUSEA and felt like I would vomit). On 01-Feb-2021, the patient experienced ABDOMINAL PAIN (belly has been hurting) and DYSGEUSIA (sour mouth). The patient was treated with SIMETICONE (GAS X) (oral) for Gastric irritation, at an unspecified dose and frequency and CALCIUM CARBONATE (TUMS [CALCIUM CARBONATE]) (oral) for Gastric irritation, at an unspecified dose and frequency. At the time of the report, ABDOMINAL DISCOMFORT (Stomach issues), ABDOMINAL PAIN (belly has been hurting), DYSGEUSIA (sour mouth) and NAUSEA (NAUSEA and felt like I would vomit) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       Reporter did not allow further contact   Most recent FOLLOW-UP information incorporated above includes: On 11-Jul-2021: Follow up was received. No new information was provided.
Sex: U
Vaccine: COVID19
Symptoms: Fall
Clinical narrative: Fell in bed after vaccine; Based on the current case data, this case has been classified as invalid. This spontaneous case was reported by a consumer and describes the occurrence of FALL (Fell in bed after vaccine) in a patient of an unknown age and gender who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.    On an unknown date, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced FALL (Fell in bed after vaccine). At the time of the report, FALL (Fell in bed after vaccine) outcome was unknown.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       This case was linked to MOD-2021-021769 (Patient Link).; Sender's Comments: Very limited information regarding this events has been provided at this time. Company assessed the events to be unlikely related to company product.
Age: 85.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site hypoaesthesia, Pain in extremity, Vaccination site erythema, Vaccination site pain, Vaccination site pruritus
Clinical narrative: arm sore; numbness; red place on arm size 2 by 4; tenderness; injection site itching; This spontaneous case was reported by a consumer and describes the occurrence of VACCINATION SITE ERYTHEMA (red place on arm size 2 by 4), VACCINATION SITE PAIN (tenderness), VACCINATION SITE PRURITUS (injection site itching), PAIN IN EXTREMITY (arm sore) and INJECTION SITE HYPOAESTHESIA (numbness) in an 85-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination.     Concurrent medical conditions included Blood pressure and Depression. Concomitant products included GABAPENTINE for Depression.    On 14-Jan-2021, the patient received dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) at an unspecified dose. On 21-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (red place on arm size 2 by 4), VACCINATION SITE PAIN (tenderness) and VACCINATION SITE PRURITUS (injection site itching). On an unknown date, the patient experienced PAIN IN EXTREMITY (arm sore) and INJECTION SITE HYPOAESTHESIA (numbness). At the time of the report, VACCINATION SITE ERYTHEMA (red place on arm size 2 by 4), VACCINATION SITE PAIN (tenderness), VACCINATION SITE PRURITUS (injection site itching), PAIN IN EXTREMITY (arm sore) and INJECTION SITE HYPOAESTHESIA (numbness) was resolving.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Treatment included Tylenol
Sex: F
Vaccine: COVID19
Symptoms: Chills, Fatigue, Malaise, Oedema peripheral, Pain in extremity
Clinical narrative: a pretty significant edema on the upper arm; paresthesia on her left hand and fingers; redness from the shoulder to the elbow; injection site redness; injection site swelling; injection site tender to the touch; a few hives; Did not fell well; chills; fatigue; arm soreness; This spontaneous case was reported by a nurse and describes the occurrence of PAIN IN EXTREMITY (arm soreness), OEDEMA PERIPHERAL (a pretty significant edema on the upper arm), PARAESTHESIA (paresthesia on her left hand and fingers), MALAISE (Did not fell well) and CHILLS (chills) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concurrent medical conditions included Asthma. Concomitant products included MONTELUKAST SODIUM (SINGULAIR), FORMOTEROL FUMARATE, MOMETASONE FUROATE (DULERA), OMEPRAZOLE and PROGESTERONE.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm soreness), CHILLS (chills) and FATIGUE (fatigue). On 17-Jan-2021, the patient experienced MALAISE (Did not fell well). On 18-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (injection site redness), VACCINATION SITE SWELLING (injection site swelling), VACCINATION SITE PAIN (injection site tender to the touch) and VACCINATION SITE URTICARIA (a few hives). On 21-Jan-2021, the patient experienced OEDEMA PERIPHERAL (a pretty significant edema on the upper arm), PARAESTHESIA (paresthesia on her left hand and fingers) and VACCINATION SITE ERYTHEMA (redness from the shoulder to the elbow). On 09-Jan-2021, PAIN IN EXTREMITY (arm soreness), CHILLS (chills) and FATIGUE (fatigue) outcome was unknown. On 18-Jan-2021, MALAISE (Did not fell well) outcome was unknown. On 25-Jan-2021, OEDEMA PERIPHERAL (a pretty significant edema on the upper arm), PARAESTHESIA (paresthesia on her left hand and fingers), VACCINATION SITE ERYTHEMA (injection site redness), VACCINATION SITE SWELLING (injection site swelling), VACCINATION SITE PAIN (injection site tender to the touch), VACCINATION SITE URTICARIA (a few hives) and VACCINATION SITE ERYTHEMA (redness from the shoulder to the elbow) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment included Benadryl, elevation of the arm and ice for the hives. Prednisolone and Keflex.
Sex: F
Vaccine: COVID19
Symptoms: Paraesthesia, Vaccination site erythema, Vaccination site pain, Vaccination site swelling, Vaccination site urticaria
Clinical narrative: a pretty significant edema on the upper arm; paresthesia on her left hand and fingers; redness from the shoulder to the elbow; injection site redness; injection site swelling; injection site tender to the touch; a few hives; Did not fell well; chills; fatigue; arm soreness; This spontaneous case was reported by a nurse and describes the occurrence of PAIN IN EXTREMITY (arm soreness), OEDEMA PERIPHERAL (a pretty significant edema on the upper arm), PARAESTHESIA (paresthesia on her left hand and fingers), MALAISE (Did not fell well) and CHILLS (chills) in a 55-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 012L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concurrent medical conditions included Asthma. Concomitant products included MONTELUKAST SODIUM (SINGULAIR), FORMOTEROL FUMARATE, MOMETASONE FUROATE (DULERA), OMEPRAZOLE and PROGESTERONE.    On 07-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 07-Jan-2021, the patient experienced PAIN IN EXTREMITY (arm soreness), CHILLS (chills) and FATIGUE (fatigue). On 17-Jan-2021, the patient experienced MALAISE (Did not fell well). On 18-Jan-2021, the patient experienced VACCINATION SITE ERYTHEMA (injection site redness), VACCINATION SITE SWELLING (injection site swelling), VACCINATION SITE PAIN (injection site tender to the touch) and VACCINATION SITE URTICARIA (a few hives). On 21-Jan-2021, the patient experienced OEDEMA PERIPHERAL (a pretty significant edema on the upper arm), PARAESTHESIA (paresthesia on her left hand and fingers) and VACCINATION SITE ERYTHEMA (redness from the shoulder to the elbow). On 09-Jan-2021, PAIN IN EXTREMITY (arm soreness), CHILLS (chills) and FATIGUE (fatigue) outcome was unknown. On 18-Jan-2021, MALAISE (Did not fell well) outcome was unknown. On 25-Jan-2021, OEDEMA PERIPHERAL (a pretty significant edema on the upper arm), PARAESTHESIA (paresthesia on her left hand and fingers), VACCINATION SITE ERYTHEMA (injection site redness), VACCINATION SITE SWELLING (injection site swelling), VACCINATION SITE PAIN (injection site tender to the touch), VACCINATION SITE URTICARIA (a few hives) and VACCINATION SITE ERYTHEMA (redness from the shoulder to the elbow) outcome was unknown. Not Provided      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Treatment included Benadryl, elevation of the arm and ice for the hives. Prednisolone and Keflex.
Age: 72.0
Sex: F
Vaccine: COVID19
Symptoms: Feeling hot, Headache, Rash, Rash macular
Clinical narrative: Rashes are warm to touch; Red blotchy patch on the left leg 3inches in diameter and the right leg was a smaller rash.; Rashes on both her legs; Minor headache; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of FEELING HOT (Rashes are warm to touch), RASH MACULAR (Red blotchy patch on the left leg 3inches in diameter and the right leg was a smaller rash.), RASH (Rashes on both her legs) and HEADACHE (Minor headache) in a 72-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 013L20A) for COVID-19 vaccination.     Concurrent medical conditions included Allergy.  On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 15-Jan-2021, the patient experienced HEADACHE (Minor headache).   On 31-Jan-2021, the patient experienced FEELING HOT (Rashes are warm to touch), RASH MACULAR (Red blotchy patch on the left leg 3inches in diameter and the right leg was a smaller rash.) and RASH (Rashes on both her legs). The patient was treated with HYDROCORTISONE (topical) on 01-Feb-2021 for Allergy, at an unspecified dose and frequency.   On 15-Jan-2021, HEADACHE (Minor headache) had resolved. At the time of the report, FEELING HOT (Rashes are warm to touch), RASH MACULAR (Red blotchy patch on the left leg 3inches in diameter and the right leg was a smaller rash.) and RASH (Rashes on both her legs) had not resolved.       The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter.
Sex: F
Vaccine: COVID19
Symptoms: Pruritus, Rash
Clinical narrative: rash on arm, mild to moderate, itching keeps her up at night, seems to be spreading; itching keeps her up at night; This spontaneous case was reported by a consumer and describes the occurrence of RASH (rash on arm, mild to moderate, itching keeps her up at night, seems to be spreading) and PRURITUS (itching keeps her up at night) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, the patient experienced RASH (rash on arm, mild to moderate, itching keeps her up at night, seems to be spreading) and PRURITUS (itching keeps her up at night). At the time of the report, RASH (rash on arm, mild to moderate, itching keeps her up at night, seems to be spreading) and PRURITUS (itching keeps her up at night) outcome was unknown. Not Provided    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Chills, Discomfort, Headache, Hyperhidrosis, Myalgia
Clinical narrative: Headaches; Chills; Sweats; Body aches/ Myalgia; Fever; Very uncomfortable; Soreness in right arm; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Soreness in right arm), HEADACHE (Headaches), CHILLS (Chills), HYPERHIDROSIS (Sweats) and MYALGIA (Body aches/ Myalgia) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K208A and 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included ATORVASTATIN, CLARITHROMYCIN (CLARITIN [CLARITHROMYCIN]), CALCIUM, VITAMIN D [VITAMIN D NOS], UBIDECARENONE (CO Q10) and ZINC for an unknown indication.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Jan-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (Soreness in right arm). On an unknown date, the patient experienced HEADACHE (Headaches), CHILLS (Chills), HYPERHIDROSIS (Sweats), MYALGIA (Body aches/ Myalgia), PYREXIA (Fever) and DISCOMFORT (Very uncomfortable). At the time of the report, PAIN IN EXTREMITY (Soreness in right arm), HEADACHE (Headaches), CHILLS (Chills), HYPERHIDROSIS (Sweats), MYALGIA (Body aches/ Myalgia), PYREXIA (Fever) and DISCOMFORT (Very uncomfortable) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pyrexia (97-99): 100.7 High.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Pain in extremity, Pyrexia
Clinical narrative: Headaches; Chills; Sweats; Body aches/ Myalgia; Fever; Very uncomfortable; Soreness in right arm; This spontaneous case was reported by a nurse (subsequently medically confirmed) and describes the occurrence of PAIN IN EXTREMITY (Soreness in right arm), HEADACHE (Headaches), CHILLS (Chills), HYPERHIDROSIS (Sweats) and MYALGIA (Body aches/ Myalgia) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 039K208A and 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event. Concomitant products included ATORVASTATIN, CLARITHROMYCIN (CLARITIN [CLARITHROMYCIN]), CALCIUM, VITAMIN D [VITAMIN D NOS], UBIDECARENONE (CO Q10) and ZINC for an unknown indication.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 25-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 25-Jan-2021,  after starting mRNA-1273 (Moderna COVID-19 Vaccine), the patient experienced PAIN IN EXTREMITY (Soreness in right arm). On an unknown date, the patient experienced HEADACHE (Headaches), CHILLS (Chills), HYPERHIDROSIS (Sweats), MYALGIA (Body aches/ Myalgia), PYREXIA (Fever) and DISCOMFORT (Very uncomfortable). At the time of the report, PAIN IN EXTREMITY (Soreness in right arm), HEADACHE (Headaches), CHILLS (Chills), HYPERHIDROSIS (Sweats), MYALGIA (Body aches/ Myalgia), PYREXIA (Fever) and DISCOMFORT (Very uncomfortable) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Pyrexia (97-99): 100.7 High.     For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   No treatment information was provided.
Age: 67.0
Sex: F
Vaccine: COVID19
Symptoms: Eye swelling, Fatigue, Pain in extremity, Periorbital swelling
Clinical narrative: Woke up with one eye that was puffy; Both eyes swollen; Left arm really sore; Felt tired; This spontaneous case was reported by a consumer and describes the occurrence of PERIORBITAL SWELLING (Woke up with one eye that was puffy), EYE SWELLING (Both eyes swollen), PAIN IN EXTREMITY (Left arm really sore) and FATIGUE (Felt tired) in a 67-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 023M20A) for COVID-19 vaccination.     Concurrent medical conditions included Drug allergy (Patient is allergic to kidney medication).  On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 18-Feb-2021, the patient experienced PERIORBITAL SWELLING (Woke up with one eye that was puffy), EYE SWELLING (Both eyes swollen), PAIN IN EXTREMITY (Left arm really sore) and FATIGUE (Felt tired). At the time of the report, PERIORBITAL SWELLING (Woke up with one eye that was puffy), EYE SWELLING (Both eyes swollen), PAIN IN EXTREMITY (Left arm really sore) and FATIGUE (Felt tired) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   It is reported that on 18-FEB-2021, patient took medication for symptoms as Warm Compresses and patient is continue to take medication regularly for Blood pressure. Concomitant product use was not provided by the reporter.
Age: 64.0
Sex: F
Vaccine: COVID19
Symptoms: Urinary tract infection
Clinical narrative: UTI; This spontaneous case was reported by a consumer and describes the occurrence of URINARY TRACT INFECTION (UTI) in a 64-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concomitant products included CALCIUM and MULTIVITAMINS [VITAMINS NOS] for an unknown indication.   On 11-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form.   On 18-Feb-2021, the patient experienced URINARY TRACT INFECTION (UTI). The patient was treated with ANTIBIOTICS for UTI, at an unspecified dose and frequency.   At the time of the report, URINARY TRACT INFECTION (UTI) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.
Age: 62.0
Sex: F
Vaccine: COVID19
Symptoms: Rash macular, Vaccination site pain, Vaccination site warmth
Clinical narrative: Two blotchy spots at the injection site; vaccination site warmth; vaccination site pain; This spontaneous case was reported by a consumer and describes the occurrence of RASH MACULAR (Two blotchy spots at the injection site), VACCINATION SITE PAIN (vaccination site pain) and VACCINATION SITE WARMTH (vaccination site warmth) in a 62-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 029L20A) for COVID-19 vaccination.     No Medical History information was reported.    On 18-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 02-Feb-2021, the patient experienced RASH MACULAR (Two blotchy spots at the injection site), VACCINATION SITE PAIN (vaccination site pain) and VACCINATION SITE WARMTH (vaccination site warmth). The patient was treated with HYDROCORTISONE (CORTISONE [HYDROCORTISONE]) ongoing since an unknown date at a dose of UNK dosage form. At the time of the report, RASH MACULAR (Two blotchy spots at the injection site), VACCINATION SITE PAIN (vaccination site pain) and VACCINATION SITE WARMTH (vaccination site warmth) had not resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown Route) was unknown.       No concomitant medications were reported.
Age: 85.0
Sex: M
Vaccine: COVID19
Symptoms: Dysstasia, Myalgia, Pain
Clinical narrative: Pain; every muscle in his body hurt; even getting out of bed was hard; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of PAIN (Pain), MYALGIA (every muscle in his body hurt) and DYSSTASIA (even getting out of bed was hard) in an 85-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included Multiple sclerosis (The patient had a medical history of multiple sclerosis for 30 years.) since an unknown date.    On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 13-Jan-2021, the patient experienced PAIN (Pain), MYALGIA (every muscle in his body hurt) and DYSSTASIA (even getting out of bed was hard). On 01-Feb-2021, PAIN (Pain), MYALGIA (every muscle in his body hurt) and DYSSTASIA (even getting out of bed was hard) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.       Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 36.0
Sex: F
Vaccine: COVID19
Symptoms: Dyspnoea, Electrocardiogram, Feeling abnormal, Heart rate increased, Hot flush
Clinical narrative: tachycardia/heart rate went immediately up to 166; shortness of breath; Felt hot; Felt fuzzy; This spontaneous case was reported by a physician (subsequently medically confirmed) and describes the occurrence of HEART RATE INCREASED (tachycardia/heart rate went immediately up to 166), DYSPNOEA (shortness of breath), HOT FLUSH (Felt hot) and FEELING ABNORMAL (Felt fuzzy) in a 36-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     The patient's past medical history included No adverse event. Concurrent medical conditions included Allergy to chemicals (Patient is allergic propylene glycol).    On 06-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 06-Jan-2021, the patient experienced HEART RATE INCREASED (tachycardia/heart rate went immediately up to 166), DYSPNOEA (shortness of breath), HOT FLUSH (Felt hot) and FEELING ABNORMAL (Felt fuzzy). At the time of the report, HEART RATE INCREASED (tachycardia/heart rate went immediately up to 166), DYSPNOEA (shortness of breath), HOT FLUSH (Felt hot) and FEELING ABNORMAL (Felt fuzzy) outcome was unknown. Not Provided    DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On an unknown date, Electrocardiogram: normal (normal) Patient went to see a cardiologist who performed some tests on her which was fine..     The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular), the reporter did not provide any causality assessments.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 68.0
Sex: M
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Low grade fever 99F or 100F; This spontaneous case was reported by a consumer and describes the occurrence of PYREXIA (Low grade fever 99F or 100F) in a 68-year-old male patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch nos. 016M20A and 026L20A) for COVID-19 vaccination.     The patient's past medical history included No adverse event.   On 15-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 12-Feb-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) dosage was changed to 1 dosage form. On 12-Feb-2021, the patient experienced PYREXIA (Low grade fever 99F or 100F). The patient was treated with ACETAMINOPHEN for Fever, at an unspecified dose and frequency. At the time of the report, PYREXIA (Low grade fever 99F or 100F) had not resolved.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 12-Feb-2021, Pyrexia: 99f or 100f (High) Patient had low grade fever 99F or 100F.   Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Disorientation, Hypoaesthesia, Injection site inflammation, Injection site pain, Injection site warmth
Clinical narrative: arm was numb from shoulder to elbow; warm to touch; golf ball size inflammation; searing pain; nauseated; disoriented; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nauseated), DISORIENTATION (disoriented), HYPOAESTHESIA (arm was numb from shoulder to elbow), INJECTION SITE WARMTH (warm to touch) and INJECTION SITE INFLAMMATION (golf ball size inflammation) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Jan-2021, the patient experienced NAUSEA (nauseated) and DISORIENTATION (disoriented). On 28-Jan-2021, the patient experienced HYPOAESTHESIA (arm was numb from shoulder to elbow), INJECTION SITE WARMTH (warm to touch) and INJECTION SITE INFLAMMATION (golf ball size inflammation). 28-Jan-2021, the patient experienced INJECTION SITE PAIN (searing pain). At the time of the report, NAUSEA (nauseated), DISORIENTATION (disoriented), HYPOAESTHESIA (arm was numb from shoulder to elbow), INJECTION SITE WARMTH (warm to touch), INJECTION SITE INFLAMMATION (golf ball size inflammation) and INJECTION SITE PAIN (searing pain) outcome was unknown.      Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 60.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea
Clinical narrative: arm was numb from shoulder to elbow; warm to touch; golf ball size inflammation; searing pain; nauseated; disoriented; This spontaneous case was reported by a consumer and describes the occurrence of NAUSEA (nauseated), DISORIENTATION (disoriented), HYPOAESTHESIA (arm was numb from shoulder to elbow), INJECTION SITE WARMTH (warm to touch) and INJECTION SITE INFLAMMATION (golf ball size inflammation) in a 60-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 027L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.   On 30-Dec-2020, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 27-Jan-2021, received second dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) dosage was changed to 1 dosage form. On 27-Jan-2021, the patient experienced NAUSEA (nauseated) and DISORIENTATION (disoriented). On 28-Jan-2021, the patient experienced HYPOAESTHESIA (arm was numb from shoulder to elbow), INJECTION SITE WARMTH (warm to touch) and INJECTION SITE INFLAMMATION (golf ball size inflammation). 28-Jan-2021, the patient experienced INJECTION SITE PAIN (searing pain). At the time of the report, NAUSEA (nauseated), DISORIENTATION (disoriented), HYPOAESTHESIA (arm was numb from shoulder to elbow), INJECTION SITE WARMTH (warm to touch), INJECTION SITE INFLAMMATION (golf ball size inflammation) and INJECTION SITE PAIN (searing pain) outcome was unknown.      Concomitant product use was not provided by the reporter. No treatment information was provided.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Asthma, Cough, Dyspnoea, Headache, Pain
Clinical narrative: Cough; Wheezing; Problems breathing; Body aches; triggering of her asthmatic problems; fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Cough), WHEEZING (Wheezing), DYSPNOEA (Problems breathing), PAIN (Body aches) and ASTHMA (triggering of her asthmatic problems) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history.). Concomitant products included FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR) for Asthma.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced COUGH (Cough), WHEEZING (Wheezing), DYSPNOEA (Problems breathing), PAIN (Body aches), ASTHMA (triggering of her asthmatic problems), PYREXIA (fever) and HEADACHE (Headache). On 25-Jan-2021, PYREXIA (fever) had resolved. At the time of the report, COUGH (Cough), WHEEZING (Wheezing), DYSPNOEA (Problems breathing), PAIN (Body aches), ASTHMA (triggering of her asthmatic problems) and HEADACHE (Headache) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No treatment information was provided.
Age: 48.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia, Wheezing
Clinical narrative: Cough; Wheezing; Problems breathing; Body aches; triggering of her asthmatic problems; fever; Headache; This spontaneous case was reported by a consumer and describes the occurrence of COUGH (Cough), WHEEZING (Wheezing), DYSPNOEA (Problems breathing), PAIN (Body aches) and ASTHMA (triggering of her asthmatic problems) in a 48-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 032L20A) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     The patient's past medical history included No adverse event (No reported medical history.). Concomitant products included FLUTICASONE PROPIONATE, SALMETEROL XINAFOATE (ADVAIR) for Asthma.   On 20-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On 22-Jan-2021, the patient experienced COUGH (Cough), WHEEZING (Wheezing), DYSPNOEA (Problems breathing), PAIN (Body aches), ASTHMA (triggering of her asthmatic problems), PYREXIA (fever) and HEADACHE (Headache). On 25-Jan-2021, PYREXIA (fever) had resolved. At the time of the report, COUGH (Cough), WHEEZING (Wheezing), DYSPNOEA (Problems breathing), PAIN (Body aches), ASTHMA (triggering of her asthmatic problems) and HEADACHE (Headache) outcome was unknown.      The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   No treatment information was provided.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: COVID-19, Chills, Cough, Diarrhoea, Dyspnoea
Clinical narrative: positive for covid; chills; Fever; headache; loose stool; swelling in mouth; tenderness in her mouth; slight cough; shortness of breath; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIARRHOEA (loose stool), MOUTH SWELLING (swelling in mouth), TENDERNESS (tenderness in her mouth), COUGH (slight cough) and DYSPNOEA (shortness of breath) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical history was reported.  Concomitant products included VITAMINS NOS for an unknown indication.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced DIARRHOEA (loose stool), MOUTH SWELLING (swelling in mouth), TENDERNESS (tenderness in her mouth), COUGH (slight cough), DYSPNOEA (shortness of breath), CHILLS (chills), PYREXIA (Fever) and HEADACHE (headache). On 23-Jan-2021, the patient experienced COVID-19 (positive for covid). At the time of the report, DIARRHOEA (loose stool), MOUTH SWELLING (swelling in mouth), TENDERNESS (tenderness in her mouth), COUGH (slight cough), DYSPNOEA (shortness of breath), COVID-19 (positive for covid), CHILLS (chills), PYREXIA (Fever) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Jan-2021, SARS-CoV-2 test: positive Positive.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Additional concomitant medications included blood pressure pills.  The patient went to the emergency room  on 23-Jan-2021 because of the side effects. While in the ER she was tested for COVID because of her symptoms and tested positive. The patient was experiencing a fever at that time which has gone down, had slight cough, her breathing was  better but she was having shortness of breath. She was not admitted.   On 25-Jan-2021, the patient was treated with an antibody infusion. She was told by her doctor she cannot get the second shot for 90 days because of the antibody treatment.
Age: 54.0
Sex: F
Vaccine: COVID19
Symptoms: Headache, Mouth swelling, Pyrexia, SARS-CoV-2 test, Tenderness
Clinical narrative: positive for covid; chills; Fever; headache; loose stool; swelling in mouth; tenderness in her mouth; slight cough; shortness of breath; This spontaneous case was reported by a consumer (subsequently medically confirmed) and describes the occurrence of DIARRHOEA (loose stool), MOUTH SWELLING (swelling in mouth), TENDERNESS (tenderness in her mouth), COUGH (slight cough) and DYSPNOEA (shortness of breath) in a 54-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) (batch no. 011J20a) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical history was reported.  Concomitant products included VITAMINS NOS for an unknown indication.   On 13-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. In January 2021, the patient experienced DIARRHOEA (loose stool), MOUTH SWELLING (swelling in mouth), TENDERNESS (tenderness in her mouth), COUGH (slight cough), DYSPNOEA (shortness of breath), CHILLS (chills), PYREXIA (Fever) and HEADACHE (headache). On 23-Jan-2021, the patient experienced COVID-19 (positive for covid). At the time of the report, DIARRHOEA (loose stool), MOUTH SWELLING (swelling in mouth), TENDERNESS (tenderness in her mouth), COUGH (slight cough), DYSPNOEA (shortness of breath), COVID-19 (positive for covid), CHILLS (chills), PYREXIA (Fever) and HEADACHE (headache) outcome was unknown.      DIAGNOSTIC RESULTS (normal ranges are provided in parenthesis if available): On 23-Jan-2021, SARS-CoV-2 test: positive Positive.   The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Additional concomitant medications included blood pressure pills.  The patient went to the emergency room  on 23-Jan-2021 because of the side effects. While in the ER she was tested for COVID because of her symptoms and tested positive. The patient was experiencing a fever at that time which has gone down, had slight cough, her breathing was  better but she was having shortness of breath. She was not admitted.   On 25-Jan-2021, the patient was treated with an antibody infusion. She was told by her doctor she cannot get the second shot for 90 days because of the antibody treatment.
Sex: F
Vaccine: COVID19
Symptoms: Axillary pain
Clinical narrative: pain in the arm; This spontaneous case was reported by a consumer and describes the occurrence of AXILLARY PAIN (pain in the arm) in a female patient of an unknown age who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination.     No Medical History information was reported.  On 17-Feb-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) 1 dosage form. On an unknown date, the patient experienced AXILLARY PAIN (pain in the arm). The patient was treated with PARACETAMOL (TYLENOL) at an unspecified dose and frequency. At the time of the report, AXILLARY PAIN (pain in the arm) outcome was unknown. Unknown    The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Intramuscular) was unknown.   Concomitant product use was not provided by the reporter.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Fatigue, Headache, Lymphadenopathy, Malaise
Clinical narrative: Headache, fatigue, fever, body aches, lightheaded and swollen lymph node in armpit of arm shot was injected in.   She has been taking ibuprofen and outcome still undetermined as it?s been 39 hours since she was administered shot and still not feeling well.
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Pain, Pyrexia
Clinical narrative: Headache, fatigue, fever, body aches, lightheaded and swollen lymph node in armpit of arm shot was injected in.   She has been taking ibuprofen and outcome still undetermined as it?s been 39 hours since she was administered shot and still not feeling well.
Age: 14.0
Sex: F
Vaccine: COVID19
Symptoms: Laboratory test, Magnetic resonance imaging, Sacroiliitis, Urine analysis
Clinical narrative: Sacroiliitis
Age: 53.0
Sex: F
Vaccine: COVID19
Symptoms: Blood test normal, Fatigue, Hypersomnia, Somnolence
Clinical narrative: Chronic fatigue since taking the vaccine, almost narcoleptic including taking unplanned naps.  Have not needed naps prior to this, and sometimes will sleep for hours after a full night's sleep the day before.   Overall exhaustion and my underlying bloodwork is healthy.
Age: 15.0
Sex: M
Vaccine: COVID19
Symptoms: Dizziness, Nausea, Pallor, Vomiting
Clinical narrative: Complained of dizziness, nausea and vomited clear stomach content x1.  Pale complexion.  911 activated.  Vital signs: P 85, BP 116/68, pulse ox 99%.  Released by medics.  Ambulatory, gait steady.  Per mother no allergies or medical history.
Age: 12.0
Sex: F
Vaccine: COVID19
Symptoms: Fall, Head injury, Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Fainting / Unresponsive-Mild, Additional Details: The patient was reaaly terrified about getting the Vaccine but mom decided to go ahead since his older brother got it and was fine. After the vaccination patient was fine and I moved her to the waiting area. it was at this point she fainted and fell to the ground. she did hit her head on the floor before I could catch her. I called the paramedics and after evaluations she checked out ok and all her vitals were great. Mom opted to take the patient home instead of going to the hospital
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Chest pain, Fatigue, Feeling cold, Injection site pain, Pain
Clinical narrative: Severe chills, fatigue, body ache, chest ache, fever, pain in the injection site
Age: 25.0
Sex: F
Vaccine: COVID19
Symptoms: Pyrexia
Clinical narrative: Severe chills, fatigue, body ache, chest ache, fever, pain in the injection site
Age: 51.0
Sex: F
Vaccine: COVID19
Symptoms: Injection site erythema, Injection site swelling, Injection site warmth, Lymphadenopathy, Peripheral swelling
Clinical narrative: Site: Swelling at Injection Site-Mild, Systemic: Lymph Node Swelling-Mild, Additional Details: Patient came to pharmacy with slightly swollen arm at site of injection, warm to touch and a swollen lymph node slightly red in appearance, warm to touch on the left side of patient's body near the neck. Patient was instructed to take benadryl and to draw a circle around both sites of swelling to monitor. This started about 24 hours post-vaccination. Patient was instructed to seek help at Urgent Care or ER regarding further treatment if swelling did not go away.
Age: 46.0
Sex: F
Vaccine: COVID19
Symptoms: Myocarditis, Pericarditis
Clinical narrative: Pericarditis, myocarditis
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Wrong patient
Clinical narrative: Error: Wrong Patient (documentation in EMR)-
Age: 13.0
Sex: F
Vaccine: COVID19
Symptoms: Dizziness, Syncope
Clinical narrative: Systemic: Dizziness / Lightheadness-Mild, Systemic: Fainting / Unresponsive-Mild, Additional Details: Patient received vaccine, sat for 15 mins. After 15 min patient walked around and faint. Patient recover consciousness and EMT arrived to check vitals which were all normal. Patient was followed up and feeling better.
Age: 29.0
Sex: M
Vaccine: COVID19
Symptoms: Injection site pain
Clinical narrative: Site: Pain at Injection Site-Medium, Additional Details: Patient's symptoms resolved within about 40 minutes after vaccination given. EMS was called. Patient stabilized and refused ER visit/
Age: 15.0
Sex: F
Vaccine: COVID19
Symptoms: Nausea, Vomiting
Clinical narrative: C/O nausea and vomiting.   Client stated she had not eaten anything since the day before.  Medics on site assessed client and found her condition to be stable.  Vital signs BP 106/66, pulse 73, O2 sat 98%.  Alert and oriented.  on to home.
Age: 28.0
Sex: F
Vaccine: COVID19
Symptoms: Abdominal discomfort, Hypoaesthesia, Syncope, Unresponsive to stimuli, Vomiting
Clinical narrative: Systemic: Fainting / Unresponsive-Mild, Systemic: Numbness (specify: facial area, extremities)-Mild, Additional Details: Patient fainted about 12 minutes after receiving vaccine. She had numbness in her left hand and started to feel sick to her stomach, then fainted. She became responsive, and slowly started to feel better. Patient vomited a very small amount approximately 3 minutes after becoming responsive, then felt better immediately.
Age: 31.0
Sex: F
Vaccine: COVID19
Symptoms: Rash, Rash pruritic
Clinical narrative: Systemic: Allergic: Rash (specify: facial area, extremeties)-Medium, Additional Details: itchy, diffuse rash mostly at joints
Age: 27.0
Sex: M
Vaccine: COVID19
Symptoms: Flushing, Hyperhidrosis, Hypotension, Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Mild, Systemic: Hypotension-Mild
Age: 36.0
Sex: M
Vaccine: COVID19
Symptoms: Product preparation error
Clinical narrative: Error: Diluent Administered Instead of Vaccine-
Age: 32.0
Sex: F
Vaccine: COVID19
Symptoms: Flushing, Hyperhidrosis, Pallor, Syncope, Unresponsive to stimuli
Clinical narrative: Systemic: Fainting / Unresponsive-Mild, Systemic: Flushed / Sweating-Severe, Additional Details: Patient got her vaccine and was fine but she started turning pale while she was in the the waiting area. I offered her some water to keep her hydrated and tried taking her bllod pressure but she fainted before I could get that. I laid her down on the floor, elevated her feet while my technician called 911. she Regained consciousness before paramedics arrived. They took her blood pressure and everying was withing range. she opted out of going to the hospital and was fine before she left.